GSK to pay ‘unprecedented’ $3 billion fraud charge
July 3, 2012Business Services, Sales and Marketing Avandia, Bextra, GSK, Paxil, Wellbutrin, Witty
GlaxoSmithKline will pay $3 billion in fraud charges, the largest of its kind in US history. The charges relate to …
Strategic North makes two appointments
July 3, 2012Business Services, Medical Communications, Sales and Marketing Strategic North
Healthcare strategic marketing agency Strategic North has expanded its team with the appointments of Sandra Du Cross in the role …
FDA approves Astellas’ leaky bladder drug
July 3, 2012Sales and Marketing Astellas, FDA, Myrbetriq, bladder, urology
The FDA has approved Astellas’ new overactive bladder disorder drug Myrbetriq. Myrbetriq (mirabegron), the first drug in its class, works …
GSK and Theravance post COPD pill data
July 2, 2012Research and Development, Sales and Marketing COPD, GSK, LABA, LAMA, Theravance
GSK and partner Theravance have released new data for its combination COPD drug. Results from four late-stage trials suggest that …
Cmed Clinical Services launches new corporate brochure
July 2, 2012Research and Development
Cmed Clinical Services is a long-established, flexible CRO with offices in the UK, US and Romania offering project management, clinical …
Doctors’ union the BMA appoints new chairman
July 2, 2012Medical Communications, Research and Development, Sales and Marketing BMA, Dr Mark Porter, appointment
Dr Mark Porter, a consultant anaesthetist in Coventry, has been elected new chairman of the British Medical Association’s UK Council. …
John LaMattina: FDA tries to disavow role in higher hurdles for new drugs
July 2, 2012Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing FDA, John LaMattina, Pfizer, US, discovery, drug
As evidenced by various blog posts that I have written over the past year (e.g., “Why Doesn’t the FDA Get …
EMA publishes updated diabetes guidelines
July 2, 2012Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda
The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …
Health Economics and Outcomes Research – What’s the Value?
July 2, 2012Medical Communications HEOR, clinical evidence, economic evidence, market access, value
Pricing pressure and regulatory restrictions across various healthcare industries have called for more detailed evidence of outcomes
AstraZeneca and BMS buy Amylin for $7 billion
July 2, 2012Sales and Marketing Amylin, AstraZeneca, BMS
AstraZeneca and Bristol-Myers Squibb have struck a deal to purchase diabetes specialist Amylin in a complicated agreement worth $7 billion. …
Measuring Return on Investment of Health Economics and Outcomes Research through the Cloud
July 2, 2012Medical Communications HEOR, ROI, interactive tools, market access
Health economics and outcomes research (HEOR) is a young and fascinating area of research with an engaged academic community. Methodology …
Ariad touts next generation CML treatment
June 29, 2012Research and Development, Sales and Marketing Ariad, CML, Cancer, Europe, Switzerland
Ariad Pharmaceuticals is to expand into Europe following promising results for an investigational cancer drug. The US biotech firm will …
McCann Torre Lazur wins Best of Health top prize
June 29, 2012Medical Communications Best of Health awards, Euro RSCG Life UK, IPA, Langland, McCann Torre Lazur, Torre Lazur McCann, Woolley Pau
McCann Torre Lazur and The Cement Bloc were awarded the prestigious ‘Best of Show’ awards at the 2012 IPA Best …
Quintiles offers lifeline to Merck Serono employees
June 28, 2012Manufacturing and Production Geneva, Merck Serono, Quintiles, cuts, manufacturing
Quintiles has said it will make at least 100 job offers within the next three months to workers set to …
Albemarle expands API capacity at Michigan facility
June 28, 2012Manufacturing and Production API, Albemarle, Michigan, manufacturing
Fine chemicals, polymers and catalysts specialist Albemarle has brought new manufacturing capacity for active pharmaceutical ingredients (APIs) online at its …
Growth in health spending ‘grinds to a halt’
June 28, 2012Business Services, Sales and Marketing Financial, GDP, OECD, growth, pharma
Growth in health spending slowed or fell in real terms in 2010 in almost all OECD countries, reversing a long-term …
DH admits cancer awareness campaigns failed
June 28, 2012Sales and Marketing Cancer, Department of Health, GPs, government
The government’s £9 million cancer awareness campaigns were built upon failed pilots, according to newly released data. The national awareness …
US judges vote to keep Obamacare
June 28, 2012Sales and Marketing Health reform, President Obama, US
The US Supreme Court will allow President Obama’s health reforms to stand.The nine-member Supreme Court has decided not to repeal …
Microsoft buys Yammer for $1.2 billion
June 28, 2012Medical Communications Daiichi Sankyo, Facebook, Microsoft, Yammer, social network
Microsoft has acquired Yammer, an internal social networking system for businesses, for $1.2 billion. Set up in 2008, Yammer closely …
MRN gets SMART with its clinical trial scheduling
June 28, 2012Research and Development clinical trials, electronic data capture, medical research network, mrn, patient scheduling
Medical Research Network (MRN), the unique Clinical Trial Support Organisation (CTSO) offering home trial and site nurse support as well …
Latest content
Five Facts about NHS and primary care
AI in pharma: From lab development to patient impact
